Drug Shortage Report for GLUCAGON
| Report ID | 180461 |
| Drug Identification Number | 02243297 |
| Brand name | GLUCAGON |
| Common or Proper name | Glucagon for Injection, rDNA origin |
| Company Name | ELI LILLY CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GLUCAGON |
| Strength(s) | 1MG |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | Kit containing 1 mg glucagon sterile lyophilized powder in a 3 mL vial and 1 mL prefilled diluent syringe |
| ATC code | H04AA |
| ATC description | GLYCOGENOLYTIC HORMONES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-01-10 |
| Estimated end date | 2023-02-06 |
| Actual end date | 2023-01-27 |
| Shortage status | Resolved |
| Updated date | 2023-01-28 |
| Company comments | For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
| Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-01-28 | English | Compare |
| v5 | 2023-01-27 | French | Compare |
| v4 | 2023-01-27 | English | Compare |
| v3 | 2023-01-11 | English | Compare |
| v2 | 2023-01-10 | French | Compare |
| v1 | 2023-01-10 | English | Compare |
Showing 1 to 6 of 6